drugset / Trial / NCT00610870

Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention

NCT00610870

Completed 173 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study to determine whether statin pretreatment decrease myocardial infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Timeline

Start
2007-07
Primary completion
2009-02
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg

Indications

No indication recorded.